Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of death associated with kratom use compared to opioids
Jack E. Henningfield, Oliver Grundmann, Jane K. Babin, et al.
Preventive Medicine (2019) Vol. 128, pp. 105851-105851
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use
Kirsten E. Smith, Jeffrey M. Rogers, Destiny Schriefer, et al.
Drug and Alcohol Dependence (2021) Vol. 226, pp. 108879-108879
Open Access | Times Cited: 56
Understanding Kratom Use: A Guide for Healthcare Providers
Marc T. Swogger, Kirsten E. Smith, Albert Garcia‐Romeu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
Kratom safety and toxicology in the public health context: research needs to better inform regulation
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report
Tyler Torrico, Kajal R. Patel, Nicole Nikolov, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 9
Social, psychological, and substance use characteristics of U.S. adults who use kratom: Initial findings from an online, crowdsourced study.
Kirsten E. Smith, Kelly E. Dunn, Oliver Grundmann, et al.
Experimental and Clinical Psychopharmacology (2021) Vol. 30, Iss. 6, pp. 983-996
Open Access | Times Cited: 40
Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids
David Vearrier, Oliver Grundmann
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 39
Kratom Abuse Potential 2021: An Updated Eight Factor Analysis
Jack E. Henningfield, Daniel W. Wang, Marilyn A. Huestis
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 26
Site selective C–H functionalization of Mitragyna alkaloids reveals a molecular switch for tuning opioid receptor signaling efficacy
Srijita Bhowmik, Juraj Galeta, Václav Havel, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits
Oliver Grundmann, Robert G. Hendrickson, Michael I. Greenberg
Disease-a-Month (2022) Vol. 69, Iss. 6, pp. 101442-101442
Closed Access | Times Cited: 20
Predicted Mode of Binding to and Allosteric Modulation of the μ-Opioid Receptor by Kratom’s Alkaloids with Reported Antinociception In Vivo
Yuchen Zhou, Steven Ramsey, Davide Provasi, et al.
Biochemistry (2020) Vol. 60, Iss. 18, pp. 1420-1429
Open Access | Times Cited: 28
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States
Walter C. Prozialeck, Peter C. Lamar, Michael Krupp, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 26
Is kratom (Mitragyna speciosa Korth.) use associated with ECG abnormalities? Electrocardiogram comparisons between regular kratom users and controls
Mohammad Farris Iman Leong Bin Abdullah, Kok Leng Tan, Suresh Narayanan, et al.
Clinical Toxicology (2020) Vol. 59, Iss. 5, pp. 400-408
Closed Access | Times Cited: 27
Kratom: A systematic review of toxicological issues
Sarah Kerrigan, Stephanie Basiliere
Wiley Interdisciplinary Reviews Forensic Science (2021) Vol. 4, Iss. 1
Closed Access | Times Cited: 23
Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa)
Chad Hartley, Marilyn N. Bulloch, Scott Penzak
The Journal of Clinical Pharmacology (2021) Vol. 62, Iss. 5, pp. 577-593
Closed Access | Times Cited: 19
Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant
Alessandro Vento, Simone De Persis, Sergio De Filippis, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 18
How Essential is Kratom Availability and use during COVID-19? Use Pattern Analysis Based on Survey and Social Media Data
Oliver Grundmann, Charles A. Veltri, Diana Morcos, et al.
Substance Abuse (2022) Vol. 43, Iss. 1, pp. 865-877
Open Access | Times Cited: 13
Two Single-Drug Fatal Intoxications by Mitragynine
George Behonick, Christina Vu, Larry Czarnecki, et al.
Journal of Analytical Toxicology (2022) Vol. 46, Iss. 5, pp. e110-e114
Closed Access | Times Cited: 13
Kratom use in the United States: a diverse and complex profile
Oliver Grundmann, Jane K. Babin, Jack E. Henningfield, et al.
Addiction (2020) Vol. 116, Iss. 1, pp. 202-203
Open Access | Times Cited: 20
Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study
Antonio Metastasio, Elisabeth Prevete, Darshan Singh, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 19
Kratom (Mitragyna speciosa Korth.) an overlooked medicinal plant in Malaysia
Gregory Domnic, Suresh Narayanan, Nethia Mohana‐Kumaran, et al.
Journal of Substance Use (2021) Vol. 27, Iss. 1, pp. 1-6
Closed Access | Times Cited: 16
Respiratory effects of oral mitragynine and oxycodone in a rodent model
Jack E. Henningfield, Joseph V. Rodricks, Aaron M. Magnuson, et al.
Psychopharmacology (2022) Vol. 239, Iss. 12, pp. 3793-3804
Open Access | Times Cited: 12
Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom
Julia Tobacyk, Brian J. Parks, Nakita Lovelady, et al.
International Journal of Drug Policy (2022) Vol. 108, pp. 103817-103817
Open Access | Times Cited: 11
Phytochemical analysis of water and ethanol liquid extracts prepared using freshly harvested leaves of Mitragyna speciosa (Korth.)
Thiruventhan Karunakaran, Balasingam Vicknasingam, Marek C. Chawarski
Natural Product Research (2024), pp. 1-8
Open Access | Times Cited: 2
An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021
Xiaotong Li, Patrick Ndungu, Sanya B. Taneja, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 6, pp. 1002-1011
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top